Central Drugs Standard Control Organization (CDSCO)
-
Foldax signs manufacturing agreement with Dolphin Life Science India
To enable in-country manufacturing of the TRIA polymer mitral surgical heart valve outside of the US for the first time…
Read More » -
CDSCO Sub Zonal Office and Central Drug Testing Laboratory opens in Indore, MP
Dr Manshukh Mandaviya also laid the foundation stone for various facilities in AIIMS Bhopal and inaugurated a slew of other…
Read More » -
Kriya Medical Technologies secures manufacturing license for KRIVIDA Trivus Respi Panel RT-qPCR Kit
Krivida Trivus offers simultaneous detection of, RSV (Respiratory Syncytial Virus), Influenza Viruses and SARS-CoV-2 in a single swab sample Kriya…
Read More » -
Molbio Diagnostics launches Truenat H3N2/H1N1
The test will work on the existing Truenat machines that are deployed across over 3500 PHCs/CHCs and over 1200 private…
Read More » -
AstraZeneca’s Durvalumab receives CDSCO approval in India
The molecule is used for the treatment of patients with locally advanced or metastatic Biliary Tract Cancer AstraZeneca India, a…
Read More » -
Amrita Vishwa Vidyapeetham gets CDSCO nod for world’s first synthetic jaw-bone graft
The clinical trial will be conducted on ten patients over two years Amrita Vishwa Vidyapeetham has got landmark approval from…
Read More » -
Ampio Pharma receives DCGI approval to commence AP-019 Phase II study in India
The study will utilise inhaled Ampion to treat those suffering from respiratory distress due to COVID-19 Ampio Pharmaceuticals, a biopharmaceutical…
Read More » -
CDSCO gives nod to Insightec for neurosurgery platform, Exablate 4000
The approval will enable the treatment of patients in India living with Essential Tremor, Tremor-dominant Parkinson’s Disease and neuropathic pain …
Read More » -
CoSara Diagnostics bags CDSCO clearance for Chikungunya, dengue tests
The Saragene test kits approved by the CDSCO use the company’s patented CoPrimer technology for the qualitative detection of these…
Read More » -
Cipla, Sun Pharma in licensing agreement with Lilly
To expand access to COVID-19 treatment in India Cipla and Sun Pharma have signed a royalty-free, non-exclusive voluntary licensing agreement…
Read More »
